Xilio Therapeutics, Inc. (XLO)
0.5682
0.00 (0.00%)
USD |
NASDAQ |
Feb 20, 16:00
0.5641
0.00 (0.00%)
After-Hours: 20:00
Xilio Therapeutics EPS Diluted (Quarterly) : -0.113 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
| Imunon, Inc. | -1.165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.29M |
| Revenue (Quarterly) | 19.07M |
| Total Expenses (Quarterly) | 35.35M |
| Enterprise Value | -66.67M |
| Gross Profit Margin (Quarterly) | 98.22% |
| Profit Margin (Quarterly) | -85.42% |
| Earnings Yield | -115.7% |
| Normalized Earnings Yield | -102.46 |